The TNF inhibitor treatment showed lower hazard ratios of myocardial infarction (HR = 0.50, psoriasis patient n = 8845) and stroke (incidence rate = 0.30, psoriasis patient n = 72,373) (a large cohort study) [34,35]. This evidence concerns the gene TNF and psoriasis.